PSC AN11 at Department of the Air Force

Procurement patterns and delivery vehicles for R&D - Biomedical: mRNA Vaccines and Therapeutic Platforms at Department of the Air Force (USAF).

Procurement Overview

Verified SAM.gov & FPDS Data

The Department of the Air Force (USAF) obligates an estimated $4.80B annually under PSC AN11 (R&D - Biomedical: mRNA Vaccines and Therapeutic Platforms), prioritizing certified prime vendors and specialized task order vehicles.

•Agency Spend: $4.80B

•National PSC Spend: $21.80B

•Agency Share: ~22% of national total